Ranbaxy stock nosedives 20% on USFDA restrictions

Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market......

Strong dollar dents Indian IT companies' revenues

The dollar's biggest quarterly rise against other major currencies since 2008 has undermined sales of India's IT services firms in non-U.S. markets, including Europe, in what was already a......

TCS shares slump over 9%, mcap down Rs 46,000 cr

Shares of IT bellwether TCS on Friday tumbled over 9 per cent, eroding Rs 45,824 crore from its market valuation, after its September quarter numbers failed to meet market expectations. The scrip......

'Sad to see a good CEO like Sikka step down'

'The move is a succession plan where Sikka comes on the board as vice chairman.' Former Nasscom chairman BVR Mohan Reddy said on Friday that it was very "sad" to see a "good CEO" like Vishal Sikka......